Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression

Seminars in Immunology

Volumn 13, Issue 1, 2001, Pages 11-18

  Miller, Daniel M ^a   Cebulla, Colleen M ^a   Rahill, Brian M ^a   Sedmak, Daniel D ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cytomegalovirus; Interferon; Lymphocyte; MHC class II; Transcription

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; CYTOMEGALOVIRUS; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0035054127     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2001.0291     Document Type: Article

References (83)

1. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
2. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility, complex class I heavy chains
3. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface
4. The human cytomegalovirus US11 gene product dislocates MHC class I heavy, chains from the endoplasmic reticulum
5. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
6. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
7. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate early 1 protein
8. Comparative analysis of fourteen individual human cytomegalovirus proteins for helper cell response
9. Antihuman cytomegalovirus activity, of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro
10. Murine cytomegalovirus infection inhibits IFN-gamma induced MHC class II expression on macrophages: The role of type I IFN
11. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells
12. LCMV-specific, class II- restricted cytotoxic T cells in β-2 nlicroglobulin deficient mice
13. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus
14. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4+ T cells
15. Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes
16. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4 T lymphocytes
17. Invariant chain structure and MHC class II function
18. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment
19. Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting
20. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments
21. Decreased endosomal delivery of major histocompatibility complex class II-invariant chain complexes in dynamin-deficient cells
22. A dominant-negative clathrin mutant differentially affects trafficking of molecules with distinct sorting motifs in the class II major histocompatibility complex (MHC) pathway
23. Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism
24. Endosomal proteolysis and MHC class II function
25. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading
26. HLA-DM induces CLIP dissociation from MHC class 1I αβ dimers and facilitates peptide loading
27. MHC class II restricted antigen presentation
28. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments
29. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment
30. Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures
31. Regulation of transcription of MHC class II genes
32. In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome
33. Regulation of MHC class II gene transcription
34. CREB regulates MHC class II expression in a CIITA-dependent manner
35. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency
36. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
37. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
38. Developmental extinction of major histocompatibility, complex class II gene expresion in plasmocytes is mediated by silencing of the transactivator gene CIITA
39. Quantitative control of MHC class II expression by the transactivator CIITA
40. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency
41. CIITA-Department and independent class II MHC expression revealed by a dominant negative mutant
42. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)
43. Activation of the MHC Class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1
44. Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
45. Interaction between the components of the interferon-γ receptor complex
46. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction
47. Jak2 is essential for signaling through a variety of cytokine receptors
48. STATs and gene regulation
49. Crystal structure of a tyrosine phosphorylated Stat-1 dimer bound to DNA
50. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene
51. In vivo footprinting of the IRF-1 promoter: Inducible occupation of a GAS element next to a persistent structural alteration of the DNA
52. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
53. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation
54. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells
55. CMW infection, class II antigen expression, and human kidney allograft rejection
56. Cytomegalovirus induces class II expression in rat heart endothelial cells
57. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression
58. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells
59. Cytomegalovirus- and interferon-related effects on human endothelial cells: Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma
60. Human cytomegalovirus does not induce human leukocyte antigen class II expression on arterial endothelial cells
61. Human cytomegalovirus inhibits MHC class II expression by disruption of the Jak/Stat pathway
62. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10
63. Escape of human cytomegalovirus from HLA-DR-restricted CD4+ T-cell response is mediated by repression of γ interferon-induced class II transactivator expression
64. Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes
65. Cytomegalovirus infection is associated with absence of alveolar epithelial cell HLA class II antigen expression
66. A novel mechanism for persistance of human cytomegalovirus in macrophages
67. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: An in vitro model
68. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells
69. Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility, complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ
70. The role of interferon β in cytomegalovirus-mediated inhibition of HLA-DR induction
71. Human Cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction
72. Interleukin-10 downregulates MHC class II alpha/beta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling
73. Mouse hepatitis virus (MHV-4, JHM) blocks gamma interferon-induced major histocompatibility, complex class II antigen expression on murine cerebral endothelial cells
74. Kirsten murine sarcoma virus abolishes interferon-gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line
75. Regulation of IFN gamma induced host cell MHC antigen expression by Kirsten MSV and MLV. I. Effects on class I antigen expression
76. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection
77. Inhibition of expression of major histocompatibility complex class II molecules in macrophages infected with Leishmania donovani occurs at the level of gene transcription via a cyclic AMP-independent mechanism
78. Effects of adenovirus E1A protein on interferon-signaling
79. Restoration of interferon responses of adenovirus E1A-expressing HT 1080 cell lines by overexpression of p48 protein
80. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α
81. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons a and g and double-stranded RNA
82. The EBNA2-related resistance towards alpha interferon in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF3